Reported 0 shares, down 26 (100.0%) from the prior quarter.
Reported value -100.0%; share count -100.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2022-06-30 | 7000 |
| 2022-09-30 | 0 |
| 2023-03-31 | 19 |
| 2023-06-30 | 13 |
| 2023-09-30 | 8 |
| 2023-12-31 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q4 2023 | Reduced | 0 | -26 (-100.0%) | 0 | $0 | 2024-02-13 | |
| Q3 2023 | Unchanged | 26 | 0 (0.0%) | < 0.01% | $8 | 2023-11-15 | |
| Q2 2023 | Unchanged | 26 | 0 (0.0%) | < 0.01% | $13 | 2023-08-14 | |
| Q1 2023 | New | 26 | +26 (0.0%) | < 0.01% | $19 | 2023-05-15 | |
| Q3 2022 | Reduced | 0 | -6,867 (-100.0%) | 0 | $0 | 2022-11-14 | |
| Q2 2022 | New | 6,867 | +6,867 (0.0%) | < 0.01% | $7,000 | 2022-08-15 |
Who else reported the position
18 managers reported SUNSHINE BIOPHARMA INC for Q4 2023.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL LLC | Added | 2,130,000 | +1,156,000 | < 0.01% | $578,295 | 3 qtrs |
| BRIDGEWAY CAPITAL MANAGEMENT LLC | Unchanged | 286,100 | 0 | < 0.01% | $77,676 | 7 qtrs |
| CITADEL ADVISORS LLC | New | 185,255 | +185,255 | < 0.01% | $50,297 | 1 qtr |
| RENAISSANCE TECHNOLOGIES LLC | New | 66,600 | +66,600 | < 0.01% | $18,000 | 1 qtr |
| Virtu Financial LLC | New | 23,862 | +23,862 | < 0.01% | $6,000 | 1 qtr |
| GEODE CAPITAL MANAGEMENT LLC | Unchanged | 20,179 | 0 | < 0.01% | $5,478 | 8 qtrs |
| XTX Topco Ltd | New | 17,495 | +17,495 | < 0.01% | $4,750 | 1 qtr |
| Bank of America Corporation | New | 10,000 | +10,000 | < 0.01% | $2,710 | 1 qtr |
| NATIONAL BANK OF CANADA FI | Unchanged | 6,042 | 0 | < 0.01% | $1,631 | 5 qtrs |
| UBS Group AG | Added | 2,201 | +2,200 | < 0.01% | $598 | 8 qtrs |
Filing details and methodology As reported
- Report period
- December 31, 2023
- Filed
- February 13, 2024
- Filing type
- 13F-HR
- Position type
- COM NEW
Voting authority reported
No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.